157 related articles for article (PubMed ID: 7164947)
1. Platelet-activating factor (PAF-acether): thromboxane-independent synergism with adrenaline on human platelets and recent insights into its mode of action.
Fouque F; Joseph D; Vargaftig BB
Agents Actions; 1982 Dec; 12(5-6):720-2. PubMed ID: 7164947
[TBL] [Abstract][Full Text] [Related]
2. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
Fouque F; Vargaftig BB
Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
[TBL] [Abstract][Full Text] [Related]
3. Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets.
Vargaftig BB; Fouque F; Benveniste J; Odiot J
Thromb Res; 1982 Nov; 28(4):557-73. PubMed ID: 7164036
[TBL] [Abstract][Full Text] [Related]
4. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
Vargaftig BB; Joseph D; Marlas G; Chevance LG
Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345
[TBL] [Abstract][Full Text] [Related]
5. PAF-acether may not mediate the third pathway of platelet aggregation since self-desensitization reduces the effects of low thrombin but enhances those of convulxin.
Wal F; Joseph D; Touqui L; Vargaftig BB
Thromb Haemost; 1985 Feb; 53(1):99-104. PubMed ID: 3992525
[TBL] [Abstract][Full Text] [Related]
6. Potentiation and inhibition by clonidine of PAF-acether-induced human platelet activation.
Fouque F; Vargaftig BB
Eur J Pharmacol; 1987 Mar; 135(2):211-8. PubMed ID: 3582495
[TBL] [Abstract][Full Text] [Related]
7. Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets.
Adnot S; Joseph D; Vargaftig BB
Agents Actions; 1987 Jun; 21(1-2):195-202. PubMed ID: 3115070
[TBL] [Abstract][Full Text] [Related]
8. Synergized activation of human platelets by epinephrine and platelet-activating factor-acether is adenosine diphosphate and thromboxane A2-independent.
Vargaftig BB; Fouque F; Joseph D; Odiot J; Benveniste J
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():429-33. PubMed ID: 6221558
[No Abstract] [Full Text] [Related]
9. Adrenaline/PAF acether synergism on human platelets: involvement of Hydergine.
Fouque F; Vargaftig BB
J Pharmacol; 1985; 16 Suppl 3():129-34. PubMed ID: 4094442
[TBL] [Abstract][Full Text] [Related]
10. Dissociation between inhibition of phospholipid methylation and production of PAF-acether by rabbit platelets.
Touqui L; Chignard M; Jacquemin C; Wal F; Vargaftig BB
Experientia; 1984 Apr; 40(4):374-7. PubMed ID: 6714369
[TBL] [Abstract][Full Text] [Related]
11. Synergistic actions of PAF-acether and sodium arachidonate in human platelet aggregation. 1. Studies in normal human platelet rich plasma.
Altman R; Scazziota A; Rouvier J; Cacchione R
Thromb Res; 1986 Jul; 43(1):103-11. PubMed ID: 3014677
[TBL] [Abstract][Full Text] [Related]
12. Cooperative effects of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets.
Ostermann G; Till U; Thielmann K
Thromb Res; 1984 Feb; 33(4):409-18. PubMed ID: 6710440
[TBL] [Abstract][Full Text] [Related]
13. Convulxin-induced activation of intact and of thrombin-degranulated rabbit platelets: specific crossed desensitisation with collagen.
Vargaftig BB; Joseph D; Wal F; Marlas G; Chignard M; Chevance LG
Eur J Pharmacol; 1983 Aug; 92(1-2):57-68. PubMed ID: 6628537
[TBL] [Abstract][Full Text] [Related]
14. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
[TBL] [Abstract][Full Text] [Related]
15. Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium.
Cattaneo M; Canciani MT; Mannucci PM
Thromb Haemost; 1985 Apr; 53(2):221-4. PubMed ID: 3927505
[TBL] [Abstract][Full Text] [Related]
16. 1-O-alkyl-2-acyl-sn-glycero-3-phosphorylcholine is the precursor of platelet-activating factor in stimulated rabbit platelets. Evidence for an alkylacetyl-glycerophosphorylcholine cycle.
Touqui L; Jacquemin C; Dumarey C; Vargaftig BB
Biochim Biophys Acta; 1985 Jan; 833(1):111-8. PubMed ID: 3967037
[TBL] [Abstract][Full Text] [Related]
17. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions].
Nunez D; Russo-Marie F; Benveniste J
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):215. PubMed ID: 3550639
[TBL] [Abstract][Full Text] [Related]
18. Desaggregation of PAF-acether-aggregated platelets by verapamil and TMB-8 with reversal of phosphorylation of 40K and 20K proteins.
Khan SN; Lane PA; Smith AD
Eur J Pharmacol; 1985 Jan; 107(2):189-98. PubMed ID: 3920056
[TBL] [Abstract][Full Text] [Related]
19. Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives.
Keraly CL; Benveniste J
Br J Haematol; 1982 Jun; 51(2):313-22. PubMed ID: 7082588
[TBL] [Abstract][Full Text] [Related]
20. Synergistic actions of paf-acether and sodium arachidonate in human platelet aggregation. 2. Unexpected results after aspirin intake.
Altman R; Scazziota A
Thromb Res; 1986 Jul; 43(1):113-20. PubMed ID: 3088757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]